论文信息 - Multicenter Phase 2 Trial of the Hsp-90 Inhibitor, IPI-504 (retaspimycin hydrochloride), in Patients with Castration-Resistant Prostate Cancer - 字舞流文

Multicenter Phase 2 Trial of the Hsp-90 Inhibitor, IPI-504 (retaspimycin hydrochloride), in Patients with Castration-Resistant Prostate Cancer

W. Oh | M. Galsky | S. Srinivas | G. Bubley | W. Stadler | J. Goddard | W. Robert | J. Dunbar | F. Chu | Ross